Revatio and Pulmonary hypertension - a phase IV clinical study of FDA data

Summary:

Pulmonary hypertension is reported as a side effect among people who take Revatio (sildenafil citrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Opsumit, and have Pain.

The phase IV clinical study analyzes which people have Pulmonary hypertension when taking Revatio. It is created by eHealthMe based on reports of 44,758 people who have side effects when taking Revatio from the FDA, and is updated regularly.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.

What is Pulmonary hypertension?

Pulmonary hypertension (increase in blood pressure in the lung artery) is found to be associated with 1,430 drugs and 1,299 conditions by eHealthMe. Check the latest studies of Pulmonary hypertension.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

44,758 people reported to have side effects when taking Revatio.
Among them, 1,736 people (3.88%) have Pulmonary hypertension.

Could Revatio cause Pulmonary hypertension?

Among these 1,736 people:

How long have people been on Revatio when they have Pulmonary hypertension? *

Click here to view more results

What is the gender of people who have Pulmonary hypertension when taking Revatio? *

Click here to view

What is the age of people who have Pulmonary hypertension when taking Revatio? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Revatio and have Pulmonary hypertension?

- Check whether Pulmonary hypertension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revatio:

Revatio (44,849 reports)

Pulmonary hypertension treatments and more:

Pulmonary hypertension (98,337 reports)

How severe was Pulmonary hypertension and when was it recovered:

Pulmonary hypertension in Revatio

Expand to all the drugs that have ingredients of sildenafil citrate:

Pulmonary hypertension and drugs with ingredients of sildenafil citrate (3,809 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary hypertension:

Pulmonary hypertension (1,430 drugs)

Browse all the conditions that are associated with Pulmonary hypertension:

Pulmonary hypertension (1,299 conditions)

Related publications that referenced our studies

Jeong SY, Jeon SJ, Kim YR, Choi SS, Kwak HS, "A Rare Case of Viagra Induced Toxic Encephalopathy", Investigative Magnetic Resonance Imaging, 2016 Sep .
Jeong SY, Jeon SJ, Kim YR, Choi SS, Kwak HS, "A Rare Case of Viagra Induced Toxic Encephalopathy", Investigative Magnetic Resonance Imaging, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on sildenafil citrate (the active ingredients of Revatio) and Revatio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.